Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis

A Carroll, PJ Dyck, M de Carvalho… - Journal of Neurology …, 2022 - jnnp.bmj.com
Hereditary transthyretin amyloidosis (ATTRv) is a severe, adult-onset autosomal dominant
inherited systemic disease predominantly affecting the peripheral and autonomic nervous …

[HTML][HTML] Gastrointestinal amyloidosis: a focused review

DS Dahiya, A Kichloo, J Singh, M Albosta… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Amyloidosis, a heterogenous group of disorders, is characterized by the extracellular
deposition of autologous, insoluble, fibrillar misfolded proteins. These extracellular proteins …

Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis

Y Ando, D Adams, MD Benson, JL Berk… - Amyloid, 2022 - Taylor & Francis
The recent approval of three drugs for the treatment of amyloid transthyretin (ATTR)
amyloidosis, both hereditary and wild-type, has opened a new era in the care of these …

JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis

H Kitaoka, C Izumi, Y Izumiya, T Inomata, M Ueda… - Circulation …, 2020 - jstage.jst.go.jp
[CQ1] What is the role of 99 mTc-PYP scintigraphy (bone scintigraphy) in clinical practice for
CA?∙∙∙∙∙∙ 1655 [CQ2] The role of endomyocardial biopsy. Which site is appropriate for biopsy …

[HTML][HTML] Intestinal amyloidosis: clinical manifestations and diagnostic challenge

R Talar-Wojnarowska… - Advances in Clinical and …, 2021 - advances.umw.edu.pl
Amyloidosis is a heterogeneous group of diseases in which the extracellular deposition of
abnormal fibrillar proteins disrupts tissue structure and function. Intestinal involvement is a …

[HTML][HTML] Current and emerging therapies for hereditary transthyretin amyloidosis: strides towards a brighter future

L Obici, R Mussinelli - Neurotherapeutics, 2021 - Elsevier
The past few years have witnessed an unprecedented acceleration in the clinical
development of novel therapeutic options for hereditary transthyretin amyloidosis. Recently …

Management of transthyretin amyloidosis

A Condoluci, M Théaudin… - Swiss medical …, 2021 - research-collection.ethz.ch
Transthyretin amyloidosis (ATTR amyloidosis) is a disease caused by deposition of
transthyretin fibrils in organs and tissues, which causes their dysfunction. The clinical …

Unique phenotypes with corresponding pathology in late-onset hereditary transthyretin amyloidosis of A97S vs. V30M

HW Hsueh, CC Chao, K Chang, YM Jeng… - Frontiers in Aging …, 2022 - frontiersin.org
Objective: Hereditary transthyretin amyloidosis (ATTRv) encompass different phenotypes
among various genotypes. Analysis of the natural history and risk factors of faster …

Clinicopathological and fecal proteome evaluations in 16 dogs presenting chronic diarrhea associated with lymphangiectasia

G Rossi, A Gavazza, S Vincenzetti, S Mangiaterra… - Veterinary …, 2021 - mdpi.com
Canine intestinal lymphangiectasia (IL) is a condition characterized by variably severe
gastrointestinal signs, frequently associated with laboratory abnormalities; the research for …

[PDF][PDF] Gastrointestinal manifestations in hereditary transthyretin amyloidosis: a single-centre experience

M Luigetti, A Tortora, A Romano… - J. Gastrointest. Liver …, 2020 - academia.edu
ABSTRACT Background & Aims: Hereditary transthyretin (ATTRv) amyloidosis represents a
diagnostic challenge considering the great variability in clinical presentation and multiorgan …